Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.

Item

http://www.wikidata.org/entity/Q35780387

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.

@ast

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.

@en

type

Item

label

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.

@ast

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.

@en

prefLabel

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.

@ast

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.

@en

P1476

Aerosolized adenovirus-vectored vaccine as an alternative vaccine delivery method.

@en

P2093

Alida Ault

http://www.w3.org/2001/XMLSchema#string

Chad J Roy

http://www.w3.org/2001/XMLSchema#string

Chih-Jen Wei

http://www.w3.org/2001/XMLSchema#string

Hanne Andersen

http://www.w3.org/2001/XMLSchema#string

J Patrick Gorres

http://www.w3.org/2001/XMLSchema#string

Jason Gall

http://www.w3.org/2001/XMLSchema#string

Mario Roederer

http://www.w3.org/2001/XMLSchema#string

Satheesh K Sivasubramani

http://www.w3.org/2001/XMLSchema#string

Srinivas S Rao

http://www.w3.org/2001/XMLSchema#string

P2860

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.

Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge.

Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.

The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine.

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens.

An in vitro model to evaluate virus aerosol characteristics using a GFP-expressing adenovirus.

Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret

Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance.

P2888

1465-9921-12-153

P304

153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-12-153

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51818760

http://www.w3.org/2001/XMLSchema#string

P6179

1023815585

http://www.w3.org/2001/XMLSchema#string

P698

22103776

http://www.w3.org/2001/XMLSchema#string

P921

Adenoviridae

P932

3287261

http://www.w3.org/2001/XMLSchema#string